Medical devices, healthcare technology and the business of care
510(k) clearance · K262067

iFuse Granite Onyx Implant System

SI-BONE, INC. · Decision date Sep 23, 2026

MEDTECHLEDGER EXPLANATIONK262067

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 23, 2026 for K262067, a traditional 510(k) from SI-BONE, Inc. of Santa Clara, California, covering the iFuse Granite Onyx™ Implant System. The filing lists the implant under 21 CFR 888.3070 (Thoracolumbosacral Pedicle Screw System, Class II, product code NKB), with a subsequent product code of OLO for navigation instruments intended for use with the Medtronic StealthStation System and with Globus ExcelsiusGPS® robotic navigation. The implant is described as Ti-6Al-4V ELI per ASTM F3001, with set screws for 5.0, 5.5 and 6.0 mm titanium alloy or cobalt chrome rods.

The summary states substantial equivalence to cleared predicates on intended use, technological characteristics, materials, manufacturing methods and principles of operation, supported by simulated use and bench testing. The indications span skeletally mature and skeletally immature patients as an adjunct to fusion, with pediatric fixation limited to a posterior approach. SESE is a clearance, not a PMA approval. The summary does not report clinical outcome data, and the public record does not quantify the indication-statement differences the summary calls non-critical.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 23, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262067
Regulatory pathway
510(k) premarket notification
Applicant
SI-BONE, INC.
Product code
NKB
Decision code
SESE
Decision date
Sep 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Thoracolumbosacral Pedicle Screw System.

Applicant
SI-BONE, INC.
Product code
NKB
FDA device class
2

FDA decision timeline

  1. K262067 received

    Application receipt date recorded by FDA.

  2. K262067 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NKB

Product / regulatory recordCompanyPathwayDecision dateSource
SeaSpine Orthopedics Corporation510(k) clearanceOct 29, 2026FDA
GS Medical Co., Ltd.510(k) clearanceOct 2, 2026FDA
Tdm Co., Ltd.510(k) clearanceOct 1, 2026FDA
Duet Spine Holdings, LLC510(k) clearanceSep 30, 2026FDA
Spinal Alignment Solutions, Inc.510(k) clearanceSep 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

SI-BONE, INC.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Santa Clara, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records